US5451410A
(en)
*
|
1993-04-22 |
1995-09-19 |
Emisphere Technologies, Inc. |
Modified amino acids for encapsulating active agents
|
US5693338A
(en)
|
1994-09-29 |
1997-12-02 |
Emisphere Technologies, Inc. |
Diketopiperazine-based delivery systems
|
US5714167A
(en)
|
1992-06-15 |
1998-02-03 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US6221367B1
(en)
|
1992-06-15 |
2001-04-24 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5629020A
(en)
*
|
1994-04-22 |
1997-05-13 |
Emisphere Technologies, Inc. |
Modified amino acids for drug delivery
|
US6099856A
(en)
|
1992-06-15 |
2000-08-08 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US6331318B1
(en)
|
1994-09-30 |
2001-12-18 |
Emisphere Technologies Inc. |
Carbon-substituted diketopiperazine delivery systems
|
US5447728A
(en)
*
|
1992-06-15 |
1995-09-05 |
Emisphere Technologies, Inc. |
Desferrioxamine oral delivery system
|
US5443841A
(en)
|
1992-06-15 |
1995-08-22 |
Emisphere Technologies, Inc. |
Proteinoid microspheres and methods for preparation and use thereof
|
US5578323A
(en)
|
1992-06-15 |
1996-11-26 |
Emisphere Technologies, Inc. |
Proteinoid carriers and methods for preparation and use thereof
|
US5541155A
(en)
*
|
1994-04-22 |
1996-07-30 |
Emisphere Technologies, Inc. |
Acids and acid salts and their use in delivery systems
|
AU658608B2
(en)
*
|
1991-03-25 |
1995-04-27 |
Astellas Pharma Europe B.V. |
Topical preparation containing a suspension of solid lipid particles
|
US5792451A
(en)
|
1994-03-02 |
1998-08-11 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
US5811127A
(en)
|
1992-06-15 |
1998-09-22 |
Emisphere Technologies, Inc. |
Desferrioxamine oral delivery system
|
US5401516A
(en)
|
1992-12-21 |
1995-03-28 |
Emisphere Technologies, Inc. |
Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
|
DE4244466C2
(de)
*
|
1992-12-24 |
1995-02-23 |
Pharmatech Gmbh |
Verfahren zur Herstellung von Pseudolatices und Mikro- oder Nanopartikeln und deren Verwendung zur Herstellung von pharmazeutischen Präparaten
|
US5885486A
(en)
*
|
1993-03-05 |
1999-03-23 |
Pharmaciaand Upjohn Ab |
Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
|
US5785976A
(en)
*
|
1993-03-05 |
1998-07-28 |
Pharmacia & Upjohn Ab |
Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
|
ES2070076B1
(es)
*
|
1993-04-20 |
1996-04-16 |
Cusi Lab |
Metodo para aumentar la estabilidad de las nanocapsulas durante su almacenamiento.
|
US5709861A
(en)
|
1993-04-22 |
1998-01-20 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
EP1025840B1
(de)
|
1993-04-22 |
2005-06-29 |
Emisphere Technologies, Inc. |
Orale Dareichungsform
|
US5958457A
(en)
|
1993-04-22 |
1999-09-28 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
US5643957A
(en)
|
1993-04-22 |
1997-07-01 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5858398A
(en)
*
|
1994-11-03 |
1999-01-12 |
Isomed Inc. |
Microparticular pharmaceutical compositions
|
US5965121A
(en)
|
1995-03-31 |
1999-10-12 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6090958A
(en)
|
1995-03-31 |
2000-07-18 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5866536A
(en)
|
1995-03-31 |
1999-02-02 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6001347A
(en)
|
1995-03-31 |
1999-12-14 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
BR9604880A
(pt)
|
1995-03-31 |
1998-05-19 |
Emisphere Tech Inc |
Composto composição forma de unidade de dosagem métodos para administração de um agente biologicamente ativo para preparar uma composição para administração de um agente ativo e para preparar um composto e composição farmacológica
|
US5989539A
(en)
|
1995-03-31 |
1999-11-23 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5650386A
(en)
|
1995-03-31 |
1997-07-22 |
Emisphere Technologies, Inc. |
Compositions for oral delivery of active agents
|
US5820881A
(en)
|
1995-04-28 |
1998-10-13 |
Emisphere Technologies, Inc. |
Microspheres of diamide-dicarboxylic acids
|
US5667806A
(en)
|
1995-06-07 |
1997-09-16 |
Emisphere Technologies, Inc. |
Spray drying method and apparatus
|
US6051258A
(en)
|
1995-06-07 |
2000-04-18 |
Emisphere Technologies, Inc. |
Proteinoid emulsions and methods for preparation and use thereof
|
US5824345A
(en)
|
1995-06-07 |
1998-10-20 |
Emisphere Technologies, Inc. |
Fragrances and flavorants
|
US5750147A
(en)
|
1995-06-07 |
1998-05-12 |
Emisphere Technologies, Inc. |
Method of solubilizing and encapsulating itraconazole
|
GB2320248B
(en)
|
1995-09-11 |
1999-04-14 |
Emisphere Tech Inc |
Method for preparing omega-aminoalkanoic acid derivatives from cycloalkanones
|
EP0904065A4
(de)
|
1996-06-14 |
2000-06-14 |
Emisphere Tech Inc |
Mikroverkapselte duftstoffe und herstellungsverfahren
|
US6440980B1
(en)
*
|
1996-09-17 |
2002-08-27 |
Avanir Pharmaceuticals |
Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
|
CN1213748C
(zh)
*
|
1996-09-17 |
2005-08-10 |
阿文尼尔药品公司 |
包括非离子表面活性剂和活性组分的组合物及其应用
|
US6313088B1
(en)
|
1997-02-07 |
2001-11-06 |
Emisphere Technologies, Inc. |
8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
|
US5804688A
(en)
|
1997-02-07 |
1998-09-08 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5876710A
(en)
|
1997-02-07 |
1999-03-02 |
Emisphere Technologies Inc. |
Compounds and compositions for delivering active agents
|
US5879681A
(en)
|
1997-02-07 |
1999-03-09 |
Emisphere Technolgies Inc. |
Compounds and compositions for delivering active agents
|
US5990166A
(en)
|
1997-02-07 |
1999-11-23 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6358504B1
(en)
|
1997-02-07 |
2002-03-19 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5939381A
(en)
|
1997-02-07 |
1999-08-17 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6060513A
(en)
|
1997-02-07 |
2000-05-09 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5863944A
(en)
|
1997-04-30 |
1999-01-26 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5962710A
(en)
|
1997-05-09 |
1999-10-05 |
Emisphere Technologies, Inc. |
Method of preparing salicyloylamino acids
|
IT1292142B1
(it)
*
|
1997-06-12 |
1999-01-25 |
Maria Rosa Gasco |
Composizione farmaceutica in forma di microparticelle lipidiche solide atte alla somministrazione parenterale
|
IL133672A0
(en)
*
|
1997-06-27 |
2001-04-30 |
Vivorx Pharmaceuticals Inc |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
EP3266450A1
(de)
*
|
1997-06-27 |
2018-01-10 |
Abraxis BioScience, LLC |
Neuartige formulierungen von pharmakologischen wirkstoffen, verfahren zur herstellung davon und verfahren zur verwendung davon
|
IT1296914B1
(it)
|
1997-12-01 |
1999-08-03 |
Maria Rosa Gasco |
Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
|
IT1298575B1
(it)
*
|
1998-02-06 |
2000-01-12 |
Vectorpharma Int |
Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di
|
IT1303787B1
(it)
*
|
1998-11-25 |
2001-02-23 |
Maria Rosa Gasco |
"nanosfere lipidiche solide atte ad una rapida internalizzazione nellecellule"
|
DE19856728B4
(de)
*
|
1998-12-09 |
2004-04-22 |
Henkel Kgaa |
Verfahren zur Herstellung von Nanopartikeldispersionen
|
US8663692B1
(en)
|
1999-05-07 |
2014-03-04 |
Pharmasol Gmbh |
Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
|
WO2000067728A2
(de)
*
|
1999-05-07 |
2000-11-16 |
Pharmasol Gmbh |
Lipidpartikel auf der basis von mischungen von flüssigen und festen lipiden und verfahren zu ihrer herstellung
|
FR2795960B1
(fr)
*
|
1999-07-05 |
2001-10-19 |
Sanofi Elf |
Microemulsions stables pour l'administration d'acides gras a l'homme ou a l'animal, et utilisation de ces microemulsions
|
US7153525B1
(en)
*
|
2000-03-22 |
2006-12-26 |
The University Of Kentucky Research Foundation |
Microemulsions as precursors to solid nanoparticles
|
GB0009773D0
(en)
|
2000-04-19 |
2000-06-07 |
Univ Cardiff |
Particulate composition
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
US7037528B2
(en)
*
|
2000-12-22 |
2006-05-02 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US8067032B2
(en)
*
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
AU2002327179A1
(en)
|
2001-06-07 |
2002-12-16 |
University Of Kentucky Research Foundation |
Nanoscintillation systems for aqueous-based liquid scintillation counting
|
US7030082B2
(en)
*
|
2001-09-07 |
2006-04-18 |
Nobex Corporation |
Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
CA2461349C
(en)
|
2001-09-26 |
2011-11-29 |
Baxter International Inc. |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
WO2003032915A2
(en)
*
|
2001-10-16 |
2003-04-24 |
Avanir Pharmacueticals |
Viral inhibition by n-docosanol
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
DE10310021A1
(de)
|
2002-02-28 |
2003-10-23 |
Lukowski Gerold |
Pharmazeutisch oder kosmetisch wirksame Mittel aus liqidhaltigen marinen Oragnismen
|
US20060189554A1
(en)
*
|
2002-09-24 |
2006-08-24 |
Russell Mumper |
Nanoparticle-Based vaccine delivery system containing adjuvant
|
ITMI20022323A1
(it)
*
|
2002-10-31 |
2004-05-01 |
Maria Rosa Gasco |
Composizioni farmaceutiche atte al trattamento di malattie oftalmiche.
|
GB2398495B
(en)
*
|
2003-01-23 |
2007-08-22 |
Kent G Lau |
A drug delivery preparation comprising at least one anti-tumour drug and a topical carrier for the drug
|
DE10353780A1
(de)
*
|
2003-11-18 |
2005-06-23 |
Beiersdorf Ag |
Partikel aus fester Hülle und potenziell feuchtigkeitsempfindliche oder wasserunlösliche Wirkstoffe enthaltendem flüssigem Kern, Zubereitungen diese enthaltend und Verfahren zu ihrer Herstellung
|
EP1711163A2
(de)
*
|
2004-02-05 |
2006-10-18 |
Baxter International Inc. |
Unter verwendung von selbststabilisierenden mitteln hergestellte dispersionen
|
US7611733B2
(en)
*
|
2004-03-26 |
2009-11-03 |
Cell Therapeutics Europe S.R.L. |
Nanoparticle formulations of platinum compounds
|
ITMI20041151A1
(it)
*
|
2004-06-09 |
2004-09-09 |
Maria Rosa Gasco |
Nanoparticelle lipidiche come agenti veicolanti per acidi nucleici procedimento per la loro preparazione e loro uso
|
US7450133B2
(en)
*
|
2004-08-20 |
2008-11-11 |
Toshiba Corporation |
System and method for color correction
|
US20070154403A1
(en)
*
|
2006-01-05 |
2007-07-05 |
Thomas Skold |
Oral, Pulmonary and Transmucosal Delivery Composition
|
AR063704A1
(es)
|
2006-09-14 |
2009-02-11 |
Makhteshim Chem Works Ltd |
Nanoparticulas de pesticida obtenida obtenidas a partir de microemulsiones y nanoemulsiones
|
WO2008032327A2
(en)
*
|
2006-09-14 |
2008-03-20 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Organic nanoparticles obtained from microemulsions by solvent evaporation
|
ITMI20061918A1
(it)
*
|
2006-10-06 |
2008-04-07 |
Nanovector S R L |
Formulazioni adatte ad essere somministrate per via transdermica contenenti principi attivi incorporati in sln
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
EP2047838A1
(de)
*
|
2007-10-10 |
2009-04-15 |
Cognis IP Management GmbH |
Mikrokapseln auf Wachsbasis
|
DE102008035442A1
(de)
|
2008-07-26 |
2010-01-28 |
Ernst-Moritz-Arndt-Universität Greifswald |
Zubereitungen aus Artemisia Annua, ihre Umwandlung in Mikro- und Nanopartikel und ihre Verwendung
|
ITMI20090284A1
(it)
|
2009-02-26 |
2010-08-27 |
Consiglio Nazionale Ricerche |
Uso di inibitori della serina palmitoiltrasferasi per la prevenzione e il rallentamento delle degenerazioni retiniche ereditarie e relative composizioni
|
CA2763458A1
(en)
*
|
2009-06-05 |
2010-12-09 |
Sunev Pharma Solution Limited |
Topical micro-emulsions for the treatment of rheumatic disorders
|
CA2803282C
(en)
|
2009-07-06 |
2018-05-01 |
David E. Anderson |
Methods for preparing vesicles and formulations produced therefrom
|
JP5854559B2
(ja)
|
2009-07-06 |
2016-02-09 |
ヴァリエーション バイオテクノロジーズ インコーポレイテッド |
小胞を調製する方法及びこれから製造される製剤
|
EP2295044A1
(de)
|
2009-09-15 |
2011-03-16 |
Bayer Technology Services GmbH |
Verkapselung unter Verwendung von wachsartigen Substanzen
|
ES2384060B1
(es)
|
2010-03-24 |
2013-09-23 |
Lipotec S.A. |
Cápsulas de nanopartículas lipídicas.
|
CA2840079C
(en)
|
2010-07-06 |
2018-07-03 |
Variation Biotechnologies Inc. |
Compositions and methods for treating influenza
|
US10736844B2
(en)
|
2011-01-13 |
2020-08-11 |
Variation Biotechnologies Inc. |
Compositions and methods for treating viral infections
|
MX357319B
(es)
*
|
2011-01-13 |
2018-07-04 |
Variation Biotechnologies Inc |
Metodo para preparar vesiculas y formulaciones producidas de las mismas.
|
US9907758B2
(en)
|
2012-01-09 |
2018-03-06 |
Panjab University Department Of Biotechnology (Dbt) |
Process for preparing solid lipid sustained release nanoparticles for delivery of vitamins
|
EP2802353A4
(de)
|
2012-01-12 |
2015-12-02 |
Variation Biotechnologies Inc |
Zusammensetzungen und verfahren zur behandlung von virusinfektionen
|
AU2013213345A1
(en)
|
2012-01-27 |
2014-08-28 |
Variation Biotechnologies, Inc. |
Methods and compositions for therapeutic agents
|
EP2892570B1
(de)
|
2012-09-07 |
2019-02-27 |
Bracco Imaging S.p.A |
Paramagnetische feste lipidnanopartikel zur kernspinnresonanzbildgebung, die amphiphile metallkomplexe enthalten
|
US20140256810A1
(en)
*
|
2013-03-08 |
2014-09-11 |
Mcneil-Ppc, Inc. |
Low melting propionic acid derivative particles for use in oral dosage forms
|
US20140213653A1
(en)
*
|
2012-09-18 |
2014-07-31 |
Mcneil-Ppc, Inc. |
Directly compressible proprionic acid derivative particles
|
CN103110645A
(zh)
*
|
2013-03-08 |
2013-05-22 |
海南卫康制药(潜山)有限公司 |
头孢米诺钠药物组合物及其制备方法
|
CN103110643A
(zh)
*
|
2013-03-08 |
2013-05-22 |
海南卫康制药(潜山)有限公司 |
注射用头孢他啶药物组合物粉针剂
|
CN103110644A
(zh)
*
|
2013-03-08 |
2013-05-22 |
海南卫康制药(潜山)有限公司 |
注射用头孢哌酮钠舒巴坦钠药物组合物粉针剂
|
MA40859A
(fr)
*
|
2014-10-29 |
2017-09-05 |
Johnson & Johnson Consumer Inc |
Particules de cadotril
|
CN106551902B
(zh)
*
|
2015-09-17 |
2020-07-03 |
阿赖耶识(上海)生物技术有限公司 |
一种高稳定的非囊泡型纳米颗粒及其在治疗微生物感染中的应用
|
CZ307681B6
(cs)
|
2016-02-29 |
2019-02-13 |
Ústav makromolekulární chemie AV ČR, v. v. i. |
Fotoaktivovatelná nanočástice pro fotodynamické aplikace, způsob její přípravy, farmaceutická kompozice ji obsahující a jejich použití
|
WO2019208802A1
(ja)
*
|
2018-04-27 |
2019-10-31 |
凸版印刷株式会社 |
複合粒子、複合粒子の製造方法および乾燥粉体、並びに皮膚塗布用組成物および当該皮膚塗布用組成物の製造方法
|
IT201900009258A1
(it)
|
2019-06-17 |
2020-12-17 |
R Bio Transfer S R L |
Metodo per la preparazione di nanoparticelle lipidiche
|
IT201900013353A1
(it)
|
2019-07-30 |
2021-01-30 |
Univ Della Calabria |
Sistema di veicolazione di olio essenziale di bergamotto basato su nanotecnologie, metodo di preparazione del sistema e suoi usi.
|
US20230000980A1
(en)
|
2021-06-30 |
2023-01-05 |
Novocure Gmbh |
Compositions and methods for using alternating electric fields to disrupt lipid capsules
|
IT202100023570A1
(it)
|
2021-09-13 |
2023-03-13 |
Bioema S R L S Biotecnologia Energia Mat Ambiente |
Metodo per la preparazione di nanoparticelle lipidiche
|